A Repeatable Methodology for Pharma AI Visibility
AI visibility is not a one-time score. It changes as platforms update their models, as competitors publish new information, and as your own website evolves. AEO Dose uses a structured, repeatable methodology built specifically for pharma and healthcare businesses, so you can see where you stand today and track what actually changes over time.
Our approach combines pharmaceutical domain knowledge with systematic testing across AI platforms, website readiness checks and competitive benchmarking. Nothing is guessed. Every recommendation is tied to an observed gap.
Audit, Optimize, Build Authority, Measure, Repeat
AI visibility work is not a one-off project. It is a cycle. We test, improve specific and prioritized gaps, strengthen credible information about your business across relevant sources, then test again to see what has actually changed.
This cycle applies whether you start with the Free AI Visibility Check or the Full AI Visibility and AEO Readiness Audit. The difference is depth: the free check gives you a light baseline, the full audit gives you a complete, prioritized roadmap across five platforms.
Audit
Establish a baseline using relevant buyer and procurement questions across available AI platforms. We record which platforms mention you, how often, whether they cite your site directly, and how competitors appear in the same answers.
Optimize
Improve high-priority website content, question-led pages, FAQs, entity clarity and relevant structured data so AI platforms can accurately surface your capabilities. Every change is tied to a specific gap found in the audit.
Build Authority
Strengthen accurate, consistent brand information across relevant third-party sources so AI answers have credible references to cite when your name appears in a response.
Measure
Repeat testing across platforms and compare results against the previous baseline to see what has actually changed. A clear before-and-after view, not assumptions.
Repeat
Treat AI visibility as ongoing rather than a one-time fix. Platform behavior shifts, competitors publish new information and your own capabilities evolve. The cycle keeps your presence current.
Checking Organization, WebPage, FAQPage and Speakable Schema
AI systems rely on more than good writing. They rely on structured, machine-readable signals that make it easier to understand who you are, what you make and why you are credible. As part of our website AEO readiness review, we check the schema types most relevant to how pharma and healthcare content is interpreted by search and AI systems.
We also look at page structure, metadata clarity and content organization that support discovery, since schema alone does not substitute for clear, well-organized content. Optional technical conventions, where relevant, are presented as considerations to evaluate, not as guaranteed ranking factors.

Questions organized across the buyer journey
Benchmarking Brand Presence, Citation Quality and Share of Voice
Knowing your own visibility is only half the picture. The Full AI Visibility and AEO Readiness Audit compares your brand against tracked competitors across the same set of buyer questions, so you can see where you are ahead, where you are behind and where the real opportunities sit.
Questions are organized across the buyer journey: discovery, evaluation, product and capability, commercial, and support and follow-up. The benchmarking reflects how real procurement and technical buyers actually research pharma suppliers and manufacturers, not generic search terms.
| Brand | Presence | Cited | Sentiment | Freshness |
|---|---|---|---|---|
| Your Brand | ||||
| Competitor A | ||||
| Competitor B | ||||
| Competitor C |
See This Methodology Applied to Your Pharma Brand
The fastest way to understand this methodology is to see it run against your own brand. Start with the Free AI Visibility Check for a light baseline across 2 platforms and 10 questions, or talk to us about the Full AI Visibility and AEO Readiness Audit for the complete five-platform assessment with benchmarking and a prioritized action plan.
No promises of guaranteed rankings or AI recommendations. Just a clear, methodical view of where you stand and what to do next.
Every recommendation is tied to an observed gap in your specific audit results, not a generic pharma checklist.
